Health News Archive - July 11, 2005
A study shows that men with breast cancer are not at increased risk for relapse after mastectomy compared to women with breast cancer and therefore should be treated using the same guidelines as women.
By Richard Woodman LONDON (Reuters Health) - Drug maker GlaxoSmithKline has issued a "Dear Doctor" letter advising that its anti-epilepsy drug Lamictal (lamotrigine) can reduce the effectiveness of oral contraceptives.
By Megan Rauscher NEW YORK (Reuters Health) - An FDA-approved device, which is threaded into the brain's arteries, can safely retrieve blood clots and open large vessels that become blocked and lead to stroke, research indicates.
CHICAGO (Reuters) - Health insurer WellPoint Inc. said on Monday it settled class-action lawsuits for $135 million with thousands of doctors over their claims of systematic underpayment for medical services.
TOKYO (Reuters) - Japan's biggest drug maker, Takeda Pharmaceutical Co. Ltd, said on Monday it is on track to release a sleeping pill as early as September in the United States and may extend its use to treat Alzheimer's disease and other illnesses.
BANGKOK (Reuters) - The deadly bird flu virus, which has killed 55 Asians, has erupted again in Thailand despite a major campaign to eradicate it, the government said on Monday.
By Paul Thomasch NEW YORK (Reuters) - As if falling circulation, depressed advertising and competition from the Internet aren't enough, newspaper publishers face newsprint prices that are lurching toward four-year highs.
Jul. 9--Sudafed -- a popular drug for the common cold -- is off the shelves thanks to drug abusers. And each pharmacy has found its own way of handling the new state law. "Everybody has got their own policy," said Jack Joseph, pharmacist at Eisenhower Parkway Pharmacy in Macon.
Hospital costs for the most common kind of heart surgery are more than 80 percent higher in the United States than in Canada because of overheads, labor and other factors, a study said on Monday.
NEW YORK (Reuters Health) - A person's cardiorespiratory fitness is a strong predictor of their risk of developing metabolic syndrome -- a cluster of heart disease and diabetes risk factors including excess body weight, high blood pressure, high cholesterol, and high blood sugar.